Evidence map›Paper›PMID 20479976›Full record

ReviewMarine drugs2010

Conventional and unconventional antimicrobials from fish, marine invertebrates and micro-algae.

Valerie J Smith, Andrew P Desbois, Elisabeth A Dyrynda

Abstract readReview
In one paragraph

Review in Marine drugs, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Antibacterial Action of Protein Fraction Isolated fromPharmaceuticals (Basel, Switzerland) · 2024
    Article
  12. Marine MicroalgaeCurrent pharmaceutical biotechnology · 2024
    Article
  13. Article
  14. Life (Basel, Switzerland) · 2023
    Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Valerie J SmithScottish Oceans Institute, University of St Andrews, St Andrews, KY16 8LB, Scotland, UK. vjs1@st-andrews.ac.uk
Andrew P Desbois
Elisabeth A Dyrynda

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

All eukaryotic organisms, single-celled or multi-cellular, produce a diverse array of natural anti-infective agents that, in addition to conventional antimicrobial peptides, also include proteins and other molecules often not regarded as part of the innate defences. Examples range from histones, fatty acids, and other structural components of cells to pigments and regulatory proteins. These probably represent very ancient defence factors that have been re-used in new ways during evolution. This review discusses the nature, biological role in host protection and potential biotechnological uses of some of these compounds, focusing on those from fish, marine invertebrates and marine micro-algae.

Indexed as

AnimalsAnti-Infective AgentsBiological ProductsBiotechnologyEukaryotaFishesHumansInvertebratesAnti-Infective AgentsBiological Productsamphipathicityantimicrobial peptidesfatty acidsinnate defencepigments

Identifiers

PMID20479976
PMCPMC2866484

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.